Partnership Opportunities

Actively looking to connect with pharma and biotech companies driving the next wave of innate cell therapies?

As NK cells emerge on the global clinical stage as the 'future of off-the-shelf solid tumor treatment,' the 9th Innate Killer Summit stands as your premier platform to network and connect with leaders in the expanding field of innate therapy.

We work with you to build a bespoke partnership package focused on making valuable connections, cementing your role as the industry partner of choice, and generating actionable leads to ensure you met your 2024 commercial objectives. 

Experts Need Your Help With:

  • Achieving scalable engineering strategies for a commercially viable innate cell therapy with partners who can actively troubleshoot to find solutions and form long term partnerships 
  • Designing new and improved manufacturing services to scale up NK therapies in a timely and cost-effective process  
  • Engineering best practice strategies to optimize persistence and durability  
  • Optimizing current cryopreservation processed to optimize cell viability and potency post thaw 
  • Selecting the best suited preclinical models to support translation  
  • Trouble-shooting analytical solutions to better determine cell activity in vivo  

Why Partner?

  • This is a unique opportunity for lead generation and to build new relationships with senior-level decision-makers from leading pharma and biotech companies within the gene therapy potency assay field

  • Drive your brand exposure and set yourself apart from your competitors

  • Showcase your expertise to industry leaders on how you can support and streamline their drug development efforts